News

Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

We are developing vaccines that can be stored at 45 degree Celsius

Date: 21/05/2015

We are developing vaccines that can be stored at 45 degree Celsius

Dr Davinder Gill, CEO, MSD Wellcome Trust Hilleman Laboratories, explains to Business Today the innovations that his company is making in the field of vaccines to make them more affordable, accessible and less sensitive to extreme conditions

View All